skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 13,424  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Adult remove subject: Medical Research remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
“About sixty per cent I want to do it”: Health researchers’ attitudes to, and experiences of, patient and public involvement (PPI)—A qualitative interview study
Material Type:
Article
Add to My Research

“About sixty per cent I want to do it”: Health researchers’ attitudes to, and experiences of, patient and public involvement (PPI)—A qualitative interview study

Health expectations : an international journal of public participation in health care and health policy, 2019-08, Vol.22 (4), p.721-730 [Peer Reviewed Journal]

2019 The Authors published by John Wiley & Sons Ltd ;2019 The Authors Health Expectations published by John Wiley & Sons Ltd. ;COPYRIGHT 2019 John Wiley & Sons, Inc. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1369-6513 ;EISSN: 1369-7625 ;DOI: 10.1111/hex.12883 ;PMID: 30927334

Full text available

2
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
Material Type:
Article
Add to My Research

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors

The Journal of clinical investigation, 2019-05, Vol.129 (5), p.2056-2070 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2019 ;2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI99538 ;PMID: 30835255

Full text available

3
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Material Type:
Article
Add to My Research

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

The Lancet (British edition), 2012-06, Vol.379 (9834), p.2352-2363 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 23-Jun 29, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60768-5 ;PMID: 22632908 ;CODEN: LANCAO

Full text available

4
A clinical case definition of post-COVID-19 condition by a Delphi consensus
Material Type:
Article
Add to My Research

A clinical case definition of post-COVID-19 condition by a Delphi consensus

The Lancet infectious diseases, 2022-04, Vol.22 (4), p.e102-e107 [Peer Reviewed Journal]

2022 World Health Organization. Published by Elsevier Ltd.All rights reserved ;Copyright © 2022 World Health Organization. Published by Elsevier Ltd.All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;2022. World Health Organization. Published by Elsevier Ltd.All rights reserved ;2022 World Health Organization. Published by Elsevier Ltd.All rights reserved 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00703-9 ;PMID: 34951953

Full text available

5
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
Material Type:
Article
Add to My Research

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

The Lancet (British edition), 2013-05, Vol.381 (9880), p.1817-1826 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 25, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60313-X ;PMID: 23615461 ;CODEN: LANCAO

Full text available

6
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Material Type:
Article
Add to My Research

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

The Lancet (British edition), 2011-06, Vol.377 (9784), p.2181-2192 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 25-Jul 1, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60739-3 ;PMID: 21663949 ;CODEN: LANCAO

Full text available

7
What advanced cancer patients with limited treatment options know about clinical research: a qualitative study
Material Type:
Article
Add to My Research

What advanced cancer patients with limited treatment options know about clinical research: a qualitative study

Supportive care in cancer, 2017-10, Vol.25 (10), p.3235-3242 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2017 ;COPYRIGHT 2017 Springer ;Supportive Care in Cancer is a copyright of Springer, 2017. ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-017-3734-4 ;PMID: 28488050

Full text available

8
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
Material Type:
Article
Add to My Research

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial

The Lancet (British edition), 2011-03, Vol.377 (9768), p.823-836 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;2011. Elsevier Ltd ;Copyright Elsevier Limited Mar 5-Mar 11, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60096-2 ;PMID: 21334061 ;CODEN: LANCAO

Full text available

9
Genomic evidence for reinfection with SARS-CoV-2: a case study
Material Type:
Article
Add to My Research

Genomic evidence for reinfection with SARS-CoV-2: a case study

The Lancet Infectious Diseases, 2021-01, Vol.21 (1), p.52-58 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30764-7 ;PMID: 33058797

Digital Resources/Online E-Resources

10
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Material Type:
Article
Add to My Research

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

The lancet oncology, 2020-04, Vol.21 (4), p.508-518 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30074-7 ;PMID: 32135080

Full text available

11
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet (British edition), 2021-05, Vol.397 (10285), p.1637-1645 [Peer Reviewed Journal]

2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00676-0 ;PMID: 33933206

Full text available

12
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Material Type:
Article
Add to My Research

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

New England Journal of Medicine, 2021-10, Vol.385 (16), p.1474-1484 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2109072 ;PMID: 34320281

Digital Resources/Online E-Resources

13
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
Material Type:
Article
Add to My Research

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

The lancet oncology, 2020-04, Vol.21 (4), p.531-540 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30856-3 ;PMID: 32105622

Full text available

14
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Material Type:
Article
Add to My Research

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

BMJ, 2020-05, Vol.369, p.m1985-m1985 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1985 ;PMID: 32444460

Digital Resources/Online E-Resources

15
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers
Material Type:
Article
Add to My Research

Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers

PloS one, 2013-10, Vol.8 (10), p.e77251-e77251 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Pescador et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Pescador et al 2013 Pescador et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0077251 ;PMID: 24204780

Full text available

16
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Material Type:
Article
Add to My Research

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

The Lancet infectious diseases, 2022-01, Vol.22 (1), p.35-42 [Peer Reviewed Journal]

2022 ;Crown copyright © 2022 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Jan 2022 ;Crown Copyright © 2021 Published by Elsevier Ltd. 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00475-8 ;PMID: 34461056

Full text available

17
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
Material Type:
Article
Add to My Research

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

The Lancet (British edition), 2011-10, Vol.378 (9802), p.1547-1559 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 29-Nov 4, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61383-4 ;PMID: 21908036 ;CODEN: LANCAO

Full text available

18
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Material Type:
Article
Add to My Research

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

New England Journal of Medicine, 2021-10, Vol.385 (15), p.1382-1392 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102685 ;PMID: 34260849

Digital Resources/Online E-Resources

19
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Material Type:
Article
Add to My Research

The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice

Headache, 2019-01, Vol.59 (1), p.1 [Peer Reviewed Journal]

2018 American Headache Society. ;EISSN: 1526-4610 ;DOI: 10.1111/head.13456 ;PMID: 30536394

Digital Resources/Online E-Resources

20
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Material Type:
Article
Add to My Research

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30932-6 ;PMID: 32580883

Full text available

Results 1 - 20 of 13,424  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1986  (22)
  2. 1986 To 1994  (278)
  3. 1995 To 2003  (304)
  4. 2004 To 2013  (3,349)
  5. After 2013  (9,473)
  6. More options open sub menu

Resource Type 

  1. Articles  (13,418)
  2. magazinearticle  (4)
  3. Newsletter Articles  (1)
  4. Books  (1)
  5. More options open sub menu

Subject 

  1. Humans  (13,384)
  2. Science & Technology  (12,756)
  3. Female  (11,609)
  4. Male  (10,924)
  5. Middle Aged  (10,290)
  6. Life Sciences & Biomedicine  (8,218)
  7. Aged  (6,954)
  8. Medicine, Experimental  (6,640)
  9. Science & Technology - Other Topics  (4,532)
  10. Multidisciplinary Sciences  (4,529)
  11. Young Adult  (4,197)
  12. Medicine  (3,640)
  13. Hospitals  (3,490)
  14. Adolescent  (3,410)
  15. Analysis  (3,397)
  16. Care And Treatment  (3,381)
  17. Studies  (3,073)
  18. More options open sub menu

Language 

  1. English  (13,422)
  2. Japanese  (1,472)
  3. Portuguese  (34)
  4. Norwegian  (16)
  5. French  (9)
  6. Chinese  (5)
  7. Turkish  (4)
  8. Persian  (3)
  9. Russian  (2)
  10. Spanish  (2)
  11. Arabic  (1)
  12. Italian  (1)
  13. More options open sub menu

Searching Remote Databases, Please Wait